| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |